Second, beyond the absence of neuropathological confirmation, our study also lacked genetic data, particularly C9orf72 status, which would have been crucial to corroborate whether the observed effects were mediated by TDP‐43 in both bvFTD and ALS‐FTD. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.